FRIDAY, Oct. 22, 2021 (HealthDay News) — Liver disease is usually associated with alcoholism or hepatitis, but obesity and diabetes are becoming an even more dire threat for potentially fatal liver damage, a new study reveals. In fact, advanced fatty liver disease increases a person’s risk of death by nearlyContinue Reading
WEDNESDAY, Oct. 20, 2021 (HealthDay News) — A kidney grown in a genetically altered pig functioned normally after being attached to a human patient during a groundbreaking procedure performed by U.S. doctors. If the technique proves generally successful it could revolutionize organ transplant, greatly expanding the pool of available organs.Continue Reading
FRIDAY, Sept. 24, 2021 (American Heart Association News) — Men and women have similar reasons for becoming – or not becoming – an organ donor, according to a new study. Yet women appear more willing to donate their organs to family members or strangers. The results, published Sept. 24 inContinue Reading
THURSDAY, Sept. 2, 2021 (HealthDay News) — People hospitalized for COVID-19, and even some with milder cases, may suffer lasting damage to their kidneys, new research finds. The study of more than 1.7 million patients in the U.S. Veterans Affairs system adds to concerns about the lingering effects of COVIDContinue Reading
TUESDAY, Aug. 24, 2021 (HealthDay News) — Here’s some hopeful news for those who have kidney transplants: Long-term survival rates have improved over the past three decades, a review shows. “There has been a gratifying improvement in kidney transplant survival, both for patients and the kidney graft itself, from 1996Continue Reading
FRIDAY, Aug. 13, 2021 (HealthDay News) — The U.S. Food and Drug Administration on Thursday authorized a third “booster” shot of coronavirus vaccines for people with weakened immune systems, as the highly contagious Delta variant continues to surge across the country. Expanding the emergency use of the Pfizer and ModernaContinue Reading
FRIDAY, Aug. 13, 2021 (HealthDay News) — Black American liver transplant recipients have a lower survival rate than Hispanic or white patients, and a new study suggests that alcohol-related liver disease and insurance coverage are key reasons. “Our findings are a huge wake-up call that physicians and other health careContinue Reading
THURSDAY, Aug. 12, 2021 (HealthDay News) — The U.S. Food and Drug Administration plans on Thursday to authorize a third “booster” shot of coronavirus vaccine for people with weakened immune systems, as the highly contagious Delta variant surges across the country. Expanding the emergency use of the Pfizer and ModernaContinue Reading
THURSDAY, Aug. 12, 2021 (HealthDay News) — A third dose of a two-shot COVID vaccine significantly boosts transplant patients’ protection against SARS-CoV-2, according to a new study. “We knew from previous studies that two doses were not enough to produce a good immune response against COVID-19 in transplant patients,” saidContinue Reading
THURSDAY, Aug. 5, 2021 (HealthDay News) — As June 28 approached, David Beverley had been “psyching himself up” for major surgery, as a lifesaving liver donor for his ailing 60-year-old father, Peter. “But then they called us, literally the day before, and told us: ‘We’ve got to stop this. WeContinue Reading
THURSDAY, July 29, 2021 (HealthDay News) — In a finding that could mean more patients desperate for a heart transplant get a new lease on life, two new studies show that hearts from donors who abused drugs can be safely donated. In the past two decades, the U.S. opioid crisisContinue Reading
FRIDAY, July 16, 2021 (HealthDay News) — Giving a third dose of COVID-19 vaccines to adults with weakened immune systems — the immunocompromised — will be up for discussion during a U.S. Centers for Disease Control and Prevention advisory panel meeting next week. At the meeting scheduled for July 22,Continue Reading
WEDNESDAY, July 7, 2021 (HealthDay News) — COVID-19 vaccinations may not offer as much protection to people with compromised immune systems, but just how much appears to be driven by the type of underlying condition, new research suggests. “People with conditions that compromise their immune systems exhibit a wide spectrumContinue Reading
TUESDAY, June 29, 2021 (HealthDay News) — Early research suggests that CRISPR gene-editing technology may some day lead to dramatic relief for patients struggling with amyloidosis, a rare but serious disease that can trigger organ failure. “There are many different types of amyloidosis,” explained study author Dr. Julian Gillmore, aContinue Reading